Cytek Biosciences, Inc. announced that Patrik Jeanmonod has been appointed as the company?s head of corporate development analytics. Jeanmonod served as Cytek?s chief financial officer since 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.45 USD | -2.85% | -9.77% | -40.24% |
Jun. 12 | Cytek Biosciences to Seek M&A | CI |
Jun. 12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.24% | 736M | |
+4.98% | 217B | |
+7.44% | 191B | |
+28.22% | 154B | |
+33.19% | 112B | |
+1.22% | 62.75B | |
+16.51% | 53.34B | |
+1.45% | 48.88B | |
-4.53% | 39.36B | |
+2.74% | 35.73B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics